Cargando…
Nivolumab-induced Hypophysitis, Secondary Adrenal Insufficiency and Destructive Thyroiditis in a Patient with Lung Adenocarcinoma
Nivolumab-induced multiple organ immune-related adverse events (irAEs) have been described in some case reports. The symptoms of endocrinological irAEs are especially nonspecific. A 63-year-old man with a postoperative recurrence of pulmonary adenocarcinoma who was treated with nivolumab presented f...
Autores principales: | Mishima, Yuka, Fukaishi, Takahiro, Inase, Naohiko, Isogai, Susumu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443556/ https://www.ncbi.nlm.nih.gov/pubmed/30449786 http://dx.doi.org/10.2169/internalmedicine.1268-18 |
Ejemplares similares
-
MON-370 Isolated Secondary Adrenal Insufficiency in the Absence of Hypophysitis Secondary to Immune Checkpoint Inhibitors
por: Lu, Mary, et al.
Publicado: (2019) -
FRI238 A Rare Combination Of Thyroiditis And Secondary Adrenal Insufficiency Likely Secondary To Hypophysitis In A Patient Treated With Immune Checkpoint Inhibitors
por: Patel, Shivani, et al.
Publicado: (2023) -
Secondary Adrenal Insufficiency in a Patient with Metastatic Melanoma Treated with Nivolumab
por: Omata, Wataru, et al.
Publicado: (2022) -
Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis
por: Thapi, Sahityasri, et al.
Publicado: (2019) -
LBODP011 Pembrolizumab Induced Hypophysitis And Resultant Isolated ACTH Deficiency Presenting As Secondary Adrenal Insufficiency.
por: Arora, Gunjan, et al.
Publicado: (2022)